The Life Sciences industry is at the forefront of driving advances in technology and innovation to meet health and environmental challenges.

Where are you on your life science growth journey?

Life sciences businesses often execute ambitious, transformational business plans in compressed timeframes that, when implemented successfully, can drive growth to the wider economy.

We partner with you at every stage of your business’s life cycle. Our team of life science industry experts is here to help your business grow and achieve your objectives. At each step, there are a number of typical business and operational considerations, such as readiness for IPO, where we can support you with everything from finding life science investment to meeting industry regulations.

Seed funding – drug discovery/pre-clinical

We can support your business with:

• Advice on company structure, accounting policies, and cost control
• Funding support
• People issues
• Tax planning and innovation/R&D reliefs.

Development and trials – in-licensing/series A/series B funding

We help growing businesses with:

• Advice around cash flow
• Accounting and financial reporting to meet investor standards
• Valuations for external fundraising and staff incentives
• Internal due diligence on process and controls
• Advice on series A and series B funding to reduce the burden on management.

Approval – out-licensing/series C funding

We help life sciences businesses at this stage with:

• Tax advisory on patent box and transfer pricing
• Cash flow forecasts to manage capital and valuations for further funding rounds
• Employment tax compliance
• Strategic reviews, including investment in the right technology
• Exit planning and vendor due diligence.

Commercialisation and globalisation – commercial partnering

To stay focused on the science, many life sciences businesses explore outsourcing their finance function, along with HR and legal services.

Value realisation – exit or IPO

We will support you to meet the required standards for a listing, including a review of your financial track record and the need to transition to IFRS.